Scandinavian journal of gastroenterology
Serum interferon gamma-induced protein 10 in obese non-diabetic patients with metabolic dysfunction-associated steatotic liver disease.
Mohamed Fouad, Olfat Fawzy, Sally Abd El-Aziz, Moshira Ali Ibrahim, Emad Gamil Khidr
Published: 202510.1080/00365521.2025.2603580
Abstract
INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disease globally, strongly linked to obesity, insulin resistance, and metabolic syndrome. Inflammation plays a central role in…
Preview only. Read the full abstract at the source